No. 185 Managing Intell. Prop. 1 (2008-2009)

handle is hein.journals/manintpr185 and id is 1 raw text is: 
CON : DE  20  / JY 2


Managing
Intellectual INCORPORATING IPASIA
                   WWW.MANAGINGIP.COM
Property-      DECEMBER 2008 / JANUARY 2009 ISSUE 185


INTERNATIONAL
46 1 The outsourcing debate

In a sagging economy, the race to outsource IP
work is on. But companies must proceed with
caution when choosing an outsource provider,
as a wrong move could compromise securi-
ty and/or quality. So what's the best
way to ensure that cutting costs
won't jeopardise your business?

PLUS
48   An outsourcing success story
50   Top providers revealed
50   Uncertainty from the USPTO









CHINA                                                                       26  Guard your domain
26 - Domain name danger
As China's population enters the internet age, domain name disputes are becoming more
common. Brand owners need to focus on the fine print and pay attention to crucial proce-
dural changes. Dennis Cai

UNITED STATES
29   Reexamine your strategy
The US reexamination process is being employed more often in lieu of costly litigation.
But there are many factors to consider in choosing the right route. Robert Abrahamsen

INTERNATIONAL
33   SMEs tackle IP
Smaller businesses are recognising the value of IP in a global world. But their needs are
different from those of their larger counterparts. Alexander Wurzer and Paul
DiGiammarino                                                                33  Lessons for SMEs

UNITEO STATES
37   Business method mania
The Fe eral Circyit delivered a blow to business m'ethod patents in late October when it     +66%
narrowed the test for determining patent eligibility. Though not all bad, the deision has
varying implications for ditferent industries. Specialists om ffow sectors answer key        -2%
questions about the impact of the ruling                                         .  ...

EUROPE
42   A need to reconsider
While the patent system traditionally has worked well for the life sciences industry, the
heightened cost of R&D and lower drug approval rates have forced drug companies to get  MNC
creative. The results are problematic, and suggest that it may be time to establish special
rules for this sector. Patrick Duxbury and Emma Tuck
                                                                            CONTENTS CONTINUED OVERLEAF > > >


VVWW MANAGINGI:LCOM DECEMBER 2008 / JANUARY 20091

What Is HeinOnline?

HeinOnline is a subscription-based resource containing nearly 2,700 academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Short-term subscription options include 24 hours, 48 hours, or 1 week to HeinOnline with pricing starting as low as $29.95

Access to this content requires a subscription. Please visit the following page to request a quote or trial:

Already a HeinOnline Subscriber?